Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years

( views:56, downloads:0 )
Author:
ZHANG Qi()
ZHANG Rui-yan()
ZHANG Jian-sheng()
HU Jian()
YANG Zhen-kun()
ZHENG Ai-fang()
ZHANG Xian()
SHEN Wei-feng()
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 119, Issue 14, 2006
DOI:
Key Word:
myocardial infarction;elderly;angioplasty;outcome

Abstract: Background The optimal reperfusion strategy in elderly patients with ST-elevation myocardial infarction (STEMI) remains unclear. The purpose of this study was to evaluate the safety, in-hospital and one-year clinical outcomes for patients >75 years of age with STEMI receiving primary percutaneous coronary intervention (PCI),compared with those treated by conservative approach.Methods One hundred and two patients >75 years of age with STEMI presented <12 hours were randomly allocated to primary PCI (n=50) or conservative therapy only (n=52). The baseline characteristics, in-hospital outcome and major adverse cardiac events (MACE), including death, non-fatal myocardial infarction and target vessel revascularization at one-year clinical follow-up were compared between the two groups.Results Age, gender distribution, risk factors for coronary artery disease, infarct site and clinical functional status were similar between the two groups, but the patients in primary PCI group received less low-molecularweight heparin during hospitalization. Compared with conservative group, the patients in primary PCI group had significantly lower occurrence rate of re-infarction and death and shortened hospital stay. The composite endpoint for in-hospital survivals at 30-day follow-up was similar between the two groups, but one-year MACE rate was significantly lower in the primary PCI group (21.3% and 45.2%, P=0.029). Left ventricular ejection fraction was not significantly changed in both groups during follow-up. Multivariate analysis revealed that primary PCI (OR=0.34, 95% CI: 0.21-0.69, P =0.03) improved MACE-free survival rate for STEMI patients aged > 75 years.Conclusion Our results indicated that primary PCI was safe and effective in reducing in-hospital mortality and one-year MACE rate for elderly patients with STEMI.

  • [1]Antman E,Anbe DT,Armstrong PW,Bates ER,Green LA,Hand M,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction.A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guidelines for management of acute myocardial infarction).J Am Coll Cardiol 2004; 44:E1-E211.
  • [2]Mehta RH,Rathore,SS,Radford M J,Wang Y,Wang Y,Krumholz HM.Acute myocardial infarction in the elderly:differences by age.J Am Coll Cardiol 2001; 38:736-741.
  • [3]de Boer M J,Ottervanger JP,van't Hof AW,Hoorntje JC,Suryapranata H,Zijlstra F.Reperfusion therapy in elderly patients with acute myocardial infarction.A randomized comparison of primary angioplasty and thrombolytic therapy.J Am Coll Cardiol 2002; 39:1723-1728.
  • [4]The Joint European Society of Cardiology/American College of Cardiology Committee.Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardiol 2003; 36:959-969.
  • [5]Smith SC Jr,Feldman TE,Hirshfeld JW Fr,Jacobs AK,Kern M J,King SB Ⅲ,et al.ACC/AHA/SCAI guidelines update for percutaneous coronary intervention.A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001guidelines for percutaneous coronary intervention).(Accessed April 10,2006 at:http://www.acc.org)
  • [6]Goldberg R J,McCormick D,Gurwitz JH,Yarzebski J,Lessard D,Gore JM.Age related trends in short-and long-term survival afteracute myocardial infarction:a 20-year population-based perspective (1975-1995).Am J Cardiol 1998; 82:1311-1317.
  • [7]Hannan EL,Racz M J,Arani DT,Ryan T J,Walford G,McCallister BD.Short-and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction.J Am Coll Cardiol 2000;36:1194-1201.
  • [8]Brass LM,Lichtman JH,Wang Y,Gurwitz JH,Radford M J,Krumholz HM.Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction:results from the cooperative cardiovascular project.Stroke 2000; 31:1802-1811.
  • [9]Becker RC,Hochman JS,Cannon CP,Spencer FA,Ball SP,Rizzo M J,et al.Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists:observation from the thrombolysis and thrombin inhibition in myocardial infarction 9 study.J Am Coll Cardiol 1999; 33:479-487.
  • [10]Thiemann DR,Coresh J,Schulman SP,Gerstenblith G,Oetgen W J,Powe NR.Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.Circulation 2000;101:2239-2246.
  • [11]Berger AK,Radford M J,Wang Y,Krumholz HM.Thrombolytic therapy in older patients.J Am Coll Cardiol 2000; 36:366-374.
  • [12]Mehta RH,O' neill WW,Harjai K J,Cox DA,Brodie BR,Boura J,et al.Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions.Am J Cardiol 2006; 97:817-822.
  • [13]The Cardiovascular Branch of Chinese Medical Association,the Editorial Board of Chinese Journal of Cardiology,the Editorial Board of Chinese Circulation Journal.Guidelines for the diagnosis and management of Chinese patients with acute myocardial infarction.Chin J Cardiol (Chin) 2001; 29:710-725.
  • [14]Jiang SL,Ji XP,Zhang C,Wang XR,Zhang M,Zhang Y.Impact of Chinese guidelines for the management of patients with acute myocardial infarction on outcomes of hospitalized patients.Chin Med J 2006; 119:26-31.
  • [15]Batchelor WB,Anstrom K J,Muhlbaier LH,Grosswald R,Weintraub WS,O'Neill WW,et al.Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions:results in 7472 octogenarians.National cardiovascular network collaboration.J Am Coll Cardiol 2000; 36:723-730.
  • [16]Mehta RH,Granger CB,Alexander KP,Bossone E,White HD,Sketch MH.Reperfusion strategies for acute myocardial infarction in the elderly.J Am Coll Cardiol 2005; 45:471-478.
  • [17]Pfisterer M,Buser P,Osswald S,Allemann U,Amann W,Angehrn W,et al.Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy:one-year results of the randomized TIME trial.JAMA 2003;289:1117-1123.
  • [18]Zhang Q,Zhang RY,Zhang JS,Hu J,Yang ZK,Ni J,et al.One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease.Chin Med J 2006; 119:165-168.
  • [19]Presbitero P,Boccuzzi G,Pagnotta P.Drug eluting stents in acute myocardial infarction.Panminerva Med 2005;47:93-97.
  • [20]Shavelle DM,Rasouli ML,Frederick P,Gibson CM,French W J,National registry of myocardial infarction investigators.Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis).Am J Cardiol 2005;96:1227-1232.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn